Form 4 for IBO IMPACT BIOMEDICAL INC.
Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001493152-24-037044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-09-18 | 2024-09-16+ | IBO | DSS, INC. | 10% | P - Purchase | $2.65 | +57.8K | 50.0K | New | +$153.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-17 | P | A | 7,800 | $2.40 | 57,800 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |
| 2 | Common | Common Stock | 2024-09-16 | P | A | 50,000 | $2.69 | 50,000 | I By Sentinel Brokers Company, Inc. | — | — | (F1) Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc. |